In our study, CD15 expression was associated with minimal extrathyroidal extension and BRAFV600E mutation, but not with gross extrathyroidal extension and lymph node metastasis, which are more important parameters for prognosis in PTC [38]. The gene discussed is FUT4; the disease is metastatic malignant neoplasm in the lymph nodes.